Skip to main content
Top
Published in: Neurological Sciences 12/2022

16-09-2022 | Dystonia | Brief Communication

ADCY5 gene mutation: a case report

Authors: Didem Tezen, Aysegul Gunduz, Meral Erdemir Kiziltan, Cengiz Yalcinkaya, Gunes Kiziltan

Published in: Neurological Sciences | Issue 12/2022

Login to get access

Abstract

Background

ADCY5 mutation is a clinical condition that has been described in limited numbers in the literature, causing hyperkinetic movement disorder, and may be sporadic or familial.

Patient description

This report looks at the involuntary movements that started early in life in a 5-year-old girl.

Results

Patient’s electroensephalogram and cranial magnetic resonance imaging were normal. Metabolic scans were normal. ADCY5 mutation was found in whole exome sequencing of the patient who did not have a similar family history.

Conclusion

Some features such as the worsening of involuntary movements after sleep and the presence of hypotonia in our patient suggested this mutation. Our patient is resistant to more than one drug. With this report, we aimed to pave the way for better understanding of the gene and the discovery of different treatment options.
Literature
1.
go back to reference Chen DH, Méneret A, Friedman JR et al (2015) ADCY5-related dyskinesia: broader spectrum and genotype− phenotype correlations. Neurology 85:2026–2035CrossRefPubMedPubMedCentral Chen DH, Méneret A, Friedman JR et al (2015) ADCY5-related dyskinesia: broader spectrum and genotype− phenotype correlations. Neurology 85:2026–2035CrossRefPubMedPubMedCentral
2.
go back to reference Vijiaratnam N, Bhatia KP, Lang AE, Raskind WH, Espay AJ (2019) ADCY5–related dyskinesia: ımproving clinical detection of an evolving disorder. Mov Disord 6(7):512–520CrossRef Vijiaratnam N, Bhatia KP, Lang AE, Raskind WH, Espay AJ (2019) ADCY5–related dyskinesia: ımproving clinical detection of an evolving disorder. Mov Disord 6(7):512–520CrossRef
4.
go back to reference Carapito R, Paul N, Untrau M et al (2015) A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia. Mov Disord 30:423–427CrossRefPubMed Carapito R, Paul N, Untrau M et al (2015) A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia. Mov Disord 30:423–427CrossRefPubMed
5.
go back to reference Matsuoka I, Suzuki Y, Defer N, Nakanishi H, Hanoune J (1997) Differential expression of type I, II, and V adenylyl cyclase gene in the postnatal developing rat brain. J Neurochem 68:498–506CrossRefPubMed Matsuoka I, Suzuki Y, Defer N, Nakanishi H, Hanoune J (1997) Differential expression of type I, II, and V adenylyl cyclase gene in the postnatal developing rat brain. J Neurochem 68:498–506CrossRefPubMed
6.
go back to reference Roberts DCS, Koob GF, Klonoff P, Fibiger HC (1980) Extinction and recovery of cocaine selfadministration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmac Biochem Behav 12(5):781–787CrossRef Roberts DCS, Koob GF, Klonoff P, Fibiger HC (1980) Extinction and recovery of cocaine selfadministration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmac Biochem Behav 12(5):781–787CrossRef
7.
go back to reference Méneret A, Mohammad SS, Cif L, Doummar D et al (2022) Efficacy of caffeine in ADCY5-related dyskinesia: a retrospective study. Mov Disord 37(6):1294–1298CrossRefPubMed Méneret A, Mohammad SS, Cif L, Doummar D et al (2022) Efficacy of caffeine in ADCY5-related dyskinesia: a retrospective study. Mov Disord 37(6):1294–1298CrossRefPubMed
8.
go back to reference Tübing J, Bohnenpoll J, Spiegler J, Gillessen-Kaesbach G, Bäumer T, Max C et al (2018) Methylphenidate can improve chorea in NKX2.1 and ADCY5 mutation-positive patients-a report two children. Mov Disord Clin Pract 5(3):343–345CrossRefPubMedPubMedCentral Tübing J, Bohnenpoll J, Spiegler J, Gillessen-Kaesbach G, Bäumer T, Max C et al (2018) Methylphenidate can improve chorea in NKX2.1 and ADCY5 mutation-positive patients-a report two children. Mov Disord Clin Pract 5(3):343–345CrossRefPubMedPubMedCentral
9.
go back to reference Dy ME, Chang FCF, Jesus SD, Anselm I, Mahant N, Zeilman P et al (2016) Treatment of ADCY5-associated dystonia, chorea, and hyperkinetic disorders with deep brain stimulation: a multicenter case series. J Child Neurol 31(8):1027–1035CrossRefPubMed Dy ME, Chang FCF, Jesus SD, Anselm I, Mahant N, Zeilman P et al (2016) Treatment of ADCY5-associated dystonia, chorea, and hyperkinetic disorders with deep brain stimulation: a multicenter case series. J Child Neurol 31(8):1027–1035CrossRefPubMed
10.
go back to reference Doyle TB, Hayes MP, Chen DH, Raskind WH, Watts VJ (2019) Functional characterization of AC5 gain-of-function variants: impact on the molecular basis of ADCY5-related dyskinesia. Biochem Pharmacol 163:169–177CrossRefPubMedPubMedCentral Doyle TB, Hayes MP, Chen DH, Raskind WH, Watts VJ (2019) Functional characterization of AC5 gain-of-function variants: impact on the molecular basis of ADCY5-related dyskinesia. Biochem Pharmacol 163:169–177CrossRefPubMedPubMedCentral
11.
go back to reference Ferrini A, Steel D, Barwick K, Kurian M (2021) An update on the phenotype, genotype and neurobiology of ADCY5-related disease. Mov Dis 36(5):1104–1114CrossRef Ferrini A, Steel D, Barwick K, Kurian M (2021) An update on the phenotype, genotype and neurobiology of ADCY5-related disease. Mov Dis 36(5):1104–1114CrossRef
Metadata
Title
ADCY5 gene mutation: a case report
Authors
Didem Tezen
Aysegul Gunduz
Meral Erdemir Kiziltan
Cengiz Yalcinkaya
Gunes Kiziltan
Publication date
16-09-2022
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 12/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-06394-0

Other articles of this Issue 12/2022

Neurological Sciences 12/2022 Go to the issue